These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17494938)

  • 21. Does dust-associated pulmonary alveolar proteinosis represent an autoimmune disorder?
    Uzmezoglu B; Simsek C; Gulgosteren S; Gebesoglu BE
    Am J Ind Med; 2017 Jun; 60(6):591-597. PubMed ID: 28514019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice.
    Seymour JF
    Respirology; 2006 Jan; 11 Suppl():S16-22. PubMed ID: 16423263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
    Huizar I; Kavuru MS
    Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
    Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
    J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies.
    Luisetti M; Bruno P; Kadija Z; Suzuki T; Raffa S; Torrisi MR; Campo I; Mariani F; Pozzi E; Trapnell BC; Mariotta S
    Respir Care; 2011 Oct; 56(10):1608-10. PubMed ID: 21513605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis.
    Reed JA; Whitsett JA
    Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications.
    Blech M; Seeliger D; Kistler B; Bauer MM; Hafner M; Hörer S; Zeeb M; Nar H; Park JE
    Biochem J; 2012 Oct; 447(2):205-15. PubMed ID: 22839360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.
    Arai T; Kasai T; Shimizu K; Kawahara K; Katayama K; Sugimoto C; Hirose M; Okamoto H; Tachibana K; Akira M; Inoue Y
    Intern Med; 2020 Oct; 59(20):2539-2546. PubMed ID: 32611952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [pulmonary alveolar proteinosis and anti-GM-CSF antibody].
    Watanabe M; Nakata K
    Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1042-7. PubMed ID: 16846053
    [No Abstract]   [Full Text] [Related]  

  • 30. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
    Tazawa R; Nakata K; Inoue Y; Nukiwa T
    Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF.
    Bonfield TL; Barna BP; John N; Malur A; Culver DA; Kavuru MS; Thomassen MJ
    J Autoimmun; 2006 Feb; 26(1):37-41. PubMed ID: 16337108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Itoh Y; Kitamura N; Hashimoto A; Tanaka T; Motoi N; Kaneko C; Tazawa R; Nakagaki K; Arai T; Inoue Y; Nakata K
    Clin Immunol; 2013 Dec; 149(3):357-64. PubMed ID: 24211842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune Pulmonary Alveolar Proteinosis: Evidence of the Pathogenicity of GM-CSF Antibodies.
    Le Gal A; Chabrol A; Brun AL; Fraboulet S; Couderc LJ; Salvator H
    Am J Respir Crit Care Med; 2021 Dec; 204(12):e134-e135. PubMed ID: 34129433
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of pathogenic human monoclonal autoantibodies against GM-CSF.
    Wang Y; Thomson CA; Allan LL; Jackson LM; Olson M; Hercus TR; Nero TL; Turner A; Parker MW; Lopez AL; Waddell TK; Anderson GP; Hamilton JA; Schrader JW
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7832-7. PubMed ID: 23620516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies.
    Khan A; Agarwal R; Aggarwal AN
    Chest; 2012 May; 141(5):1273-1283. PubMed ID: 22016491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary alveolar proteinosis associated with dust inhalation: not secondary but autoimmune?
    Costabel U; Nakata K
    Am J Respir Crit Care Med; 2010 Mar; 181(5):427-8. PubMed ID: 20185750
    [No Abstract]   [Full Text] [Related]  

  • 37. GM-CSF autoantibodies in pulmonary alveolar proteinosis.
    Busch T; Bercker S; Kaisers U
    N Engl J Med; 2007 May; 356(19):2001-2; author reply 2002. PubMed ID: 17506160
    [No Abstract]   [Full Text] [Related]  

  • 38. Pulmonary alveolar proteinosis.
    Trapnell BC; Whitsett JA; Nakata K
    N Engl J Med; 2003 Dec; 349(26):2527-39. PubMed ID: 14695413
    [No Abstract]   [Full Text] [Related]  

  • 39. IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Motoi N; Takizawa J; Kaneko C; Kanazawa H; Tazawa R; Nakagaki K; Akagawa KS; Akasaka K; Ichiwata T; Azuma A; Nakata K
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L959-64. PubMed ID: 22367782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary alveolar proteinosis. What is the role of GM-CSF in disease pathogenesis and treatment?
    Seymour JF; Presneill JJ
    Treat Respir Med; 2004; 3(4):229-34. PubMed ID: 15350161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.